Analyzing Vivos Therapeutics (NASDAQ:VVOS) and Beauty Health (NASDAQ:SKIN)

Beauty Health (NASDAQ:SKINGet Free Report) and Vivos Therapeutics (NASDAQ:VVOSGet Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings.

Profitability

This table compares Beauty Health and Vivos Therapeutics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Beauty Health -8.11% -44.83% -3.54%
Vivos Therapeutics -86.19% -335.04% -93.58%

Earnings and Valuation

This table compares Beauty Health and Vivos Therapeutics”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Beauty Health $347.62 million 0.51 -$100.12 million ($0.42) -3.38
Vivos Therapeutics $14.58 million 1.32 -$13.58 million ($5.68) -0.58

Vivos Therapeutics has lower revenue, but higher earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Vivos Therapeutics, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 26.4% of Vivos Therapeutics shares are owned by institutional investors. 41.0% of Beauty Health shares are owned by insiders. Comparatively, 3.0% of Vivos Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Beauty Health and Vivos Therapeutics, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beauty Health 1 3 1 0 2.00
Vivos Therapeutics 0 0 2 0 3.00

Beauty Health presently has a consensus price target of $2.55, suggesting a potential upside of 79.58%. Vivos Therapeutics has a consensus price target of $6.30, suggesting a potential upside of 92.66%. Given Vivos Therapeutics’ stronger consensus rating and higher possible upside, analysts plainly believe Vivos Therapeutics is more favorable than Beauty Health.

Risk & Volatility

Beauty Health has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Comparatively, Vivos Therapeutics has a beta of 7.47, meaning that its stock price is 647% more volatile than the S&P 500.

About Beauty Health

(Get Free Report)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

About Vivos Therapeutics

(Get Free Report)

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.